These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 8988801)

  • 21. Electrodermal and vascular orienting response in schizophrenic patients: relationship to symptoms and medication.
    Schlenker R; Cohen R; Hubmann W; Mohr F; Wahlheim C; Watzl H; Werther P
    Eur Arch Psychiatry Clin Neurosci; 1995; 245(3):152-8. PubMed ID: 7669822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The arousal hypothesis of schizophrenia: current status.
    Done DJ
    Br J Hosp Med; 1990 Jun; 43(6):407. PubMed ID: 2194621
    [No Abstract]   [Full Text] [Related]  

  • 23. Electrodermal predictors of functional outcome and negative symptoms in schizophrenia.
    Schell AM; Dawson ME; Rissling A; Ventura J; Subotnik KL; Gitlin MJ; Nuechterlein KH
    Psychophysiology; 2005 Jul; 42(4):483-92. PubMed ID: 16008777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychophysiological patterns of response in schizophrenia.
    Thetford PE; Spohn HE; Everds JP
    J Nerv Ment Dis; 1974 Feb; 158(2):104-14. PubMed ID: 4149886
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuropsychological and psychophysiological correlates of psychosocial functioning in schizophrenia.
    Brekke JS; Raine A; Ansel M; Lencz T; Bird L
    Schizophr Bull; 1997; 23(1):19-28. PubMed ID: 9050110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychophysiological prodromal signs of schizophrenic relapse: a pilot study.
    Dawson ME; Schell AM; Rissling A; Ventura J; Subotnik KL; Nuechterlein KH
    Schizophr Res; 2010 Oct; 123(1):64-7. PubMed ID: 20724111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biosignals of dermal activity].
    Rathkolb O; Gallei L
    Wien Klin Wochenschr; 1993; 105(8):228-31. PubMed ID: 8506684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Third ventricle enlargement and reduced electrodermal responsiveness.
    Cannon TD; Fuhrmann M; Mednick SA; Machon RA; Parnas J; Schulsinger F
    Psychophysiology; 1988 Mar; 25(2):153-6. PubMed ID: 3399601
    [No Abstract]   [Full Text] [Related]  

  • 29. What does electrodermal activity tell us about prognosis in the schizophrenia spectrum?
    Dawson ME; Schell AM
    Schizophr Res; 2002 Mar; 54(1-2):87-93. PubMed ID: 11853982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interaction of electrodermal activity and expressed emotion in predicting symptoms in recent-onset schizophrenia.
    Subotnik KL; Schell AM; Chilingar MS; Dawson ME; Ventura J; Kelly KA; Hellemann GS; Nuechterlein KH
    Psychophysiology; 2012 Aug; 49(8):1035-8. PubMed ID: 22680838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart rate variability response to mental arithmetic stress in patients with schizophrenia: autonomic response to stress in schizophrenia.
    Castro MN; Vigo DE; Weidema H; Fahrer RD; Chu EM; de Achával D; Nogués M; Leiguarda RC; Cardinali DP; Guinjoan SM
    Schizophr Res; 2008 Feb; 99(1-3):294-303. PubMed ID: 17913466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrodermal activity as a predictor of schizophrenic relapse.
    Tarrier N; Barrowclough C
    Psychopathology; 1989; 22(6):320-4. PubMed ID: 2639381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Auditory event-related potentials and electrodermal activity in medicated and unmedicated schizophrenics.
    Roth WT; Goodale J; Pfefferbaum A
    Biol Psychiatry; 1991 Mar; 29(6):585-99. PubMed ID: 1675890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The temporal stability of electrodermal variables over a one-year period in patients with recent-onset schizophrenia and in normal subjects.
    Schell AM; Dawson ME; Nuechterlein KH; Subotnik KL; Ventura J
    Psychophysiology; 2002 Mar; 39(2):124-32. PubMed ID: 12212661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical attributes of schizophrenic skin conductance responders and non-responders.
    Gruzelier JH
    Psychol Med; 1976 May; 6(2):245-9. PubMed ID: 826921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia.
    Williams LM; Das P; Harris AW; Liddell BB; Brammer MJ; Olivieri G; Skerrett D; Phillips ML; David AS; Peduto A; Gordon E
    Am J Psychiatry; 2004 Mar; 161(3):480-9. PubMed ID: 14992974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired autonomic nervous system-habituation in those at genetic risk for schizophrenia.
    Hollister JM; Mednick SA; Brennan P; Cannon TD
    Arch Gen Psychiatry; 1994 Jul; 51(7):552-8. PubMed ID: 8031228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrodermal activity and schizophrenia: the problem of stimulus intensity modulation.
    Depue RA; Fowles DC
    Psychol Bull; 1976 Mar; 83(2):192-3. PubMed ID: 1265161
    [No Abstract]   [Full Text] [Related]  

  • 39. Psychophysiological correlates of electrodermal lability.
    Schell AM; Dawson ME; Filion DL
    Psychophysiology; 1988 Nov; 25(6):619-32. PubMed ID: 3241850
    [No Abstract]   [Full Text] [Related]  

  • 40. The perception of emotion by schizophrenic patients.
    Joseph PL; Sturgeon DA; Leff J
    Br J Psychiatry; 1992 Nov; 161():603-9. PubMed ID: 1422607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.